Precision Medicine Driving Growth In The Optical Genome Mapping Market: Strengthening the Growth Trajectory of the Optical Genome Mapping Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Optical Genome Mapping Market Through 2025?
Recent years have witnessed an exponential growth in the optical genome mapping market size. The market is predicted to rise from $0.17 billion in 2024 to $0.23 billion in 2025, representing a compound annual growth rate (CAGR) of 29.7%. This significant growth during the historical period is attributable to factors such as an upsurge in demand for superior genomic analysis tools and methodologies, enhanced research in large-scale genome identification, a growing rate of partnerships amongst instrument producers and hospitals. Further contributing to the surge is the embracing of optical genome mapping by research institutions and pharmaceutical companies due to its cost-effectiveness and proficiency in quickly analyzing large genomes accurately.

What's the Projected Size of the Global Optical Genome Mapping Market by 2029?
The market size of optical genome mapping is predicted to experience a significant surge in the near future. The market value is set to reach $0.63 billion by 2029, maintaining a compound annual growth rate (CAGR) of 29.4%. Multiple factors are expected to contribute to this growth within the projected period, including breakthroughs in genomic research, the growing requirement for precision medicine, an increase in government funding and initiatives, a strong healthcare framework, and the escalating prevalence of genetic disorders and cancer. The forecast period is also marked by several key trends, such as the progression of OGM services, initiatives in genomic research, breakthroughs in DNA mapping technologies, technological advancements, and the improvements in data analysis technologies like AI and ML put to use in genomic data processing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Top Growth Drivers in the Optical Genome Mapping Industry: What's Accelerating the Market?
The continued growth of the optical genome mapping market is expected to be spurred by the expanding demand for precision medicine. This medical approach optimizes healing and prevention strategies based on unique factors, such as genetic composition, lifestyle choices, and environmental influences. A rise in chronic disease cases, progress in genomic technologies, an uptick in the allocation of funds and investments, and a patient preference for personal healthcare are some elements fueling demand for precision medicine. Optical genome mapping plays a key role in enhancing precision medicine by offering an intricate, accurate depiction of genomic changes linked to diverse afflictions. For example, the Personalized Medicine Coalition, an American non-profit organization, disclosed in February 2024 that the FDA gave approval to 16 new personalized treatments for patients suffering from rare diseases in 2023, a significant increase from the six approved in 2022. Consequently, this surge in demand for precision medicine is stimulating the growth of the optical genome mapping market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

What Trends Will Shape the Optical Genome Mapping Market Through 2029 and Beyond?
Leading corporations in the optical genome mapping market are leveraging laboratory-developed tests (LDTs), based on optical genome mapping, to amplify their diagnostic capacity and offer more precise genomic data. These laboratory-developed tests (LDTs) which are built and utilized in individual clinical laboratories apply optical genome mapping (OGM) technology. An example occurred in September 2022, when Bionano Genomics Inc., a genome analysis software provider from the US, introduced an optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD). This adoption of OGM-based LDT will empower Bionano Laboratories to provide services to clients interested in incorporating OGM into their diagnostics, as well as in their research ventures with hospitals, pharmaceutical firms and other entities.

What Are the Main Segments in the Optical Genome Mapping Market?
The optical genome mapping market covered in this report is segmented -

1) By Product: Instruments, Consumables And Reagents, Software, Services
2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:
1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices
2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells
3) By Software: Data Analysis Software, Image Processing Software, Mapping Software
4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Which Top Companies are Driving Growth in the Optical Genome Mapping Market?
Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

Which Regions Will Dominate the Optical Genome Mapping Market Through 2029?
North America was the largest region in the optical genome mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15882

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.